Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Camila Adarvez-Feresin has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Adriana D. Garro

    Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Instituto Multidisciplinario de Investigaciones Biológicas (IMIBIO-SL), Av. Ejército de los Andes 950, D5700HHW San Luis, Argentina

    3 shared publications
  • Gabriela Egly Feresin

    Instituto de Biotecnología, Facultad de Ingeniería, Universidad Nacional de San Juan, Av. Libertador General San Martin 1109 Oeste, San Juan 5400, Argentina

    2 shared publications
  • Javier Esteban Ortiz

    Instituto de Biotecnología, Facultad de Ingeniería, Universidad Nacional de San Juan, Av. Libertador General San Martín 1109 (O), San Juan 5400, Argentina

    2 shared publications
  • Ricardo Daniel Enriz

    Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Chacabuco 915, San Luis 5700, Argentina

    2 shared publications
  • Adriana Garro

    Instituto Multidisciplinario de Investigaciones Biológicas (IMIBIO-SL), Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Chacabuco 915, San Luis 5700, Argentina

    1 shared publication
  • Aleš Imramovský

    Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 95, 532 10 Pardubice, Czech Republic

    1 shared publication

Latest Publications

  • Open Access

    Structure-Based Design of New Series of Sulfonates with Potent and Specific BChE Inhibition and Anti-Inflammatory Effects

    by Siva Hariprasad Kurma, Camila Adarvez-Feresin, Oscar Parravicini, Adriana Garro, Sarka Stepankova, Jan Hosek, Karel Pauk, Jovana Lisicic, Josef Jampilek, Ricardo Daniel Enriz, et al.

    In the present work, a novel series of eleven sulfonate derivatives with potent inhibitory activity against butyrylcholinesterase (BChE) is reported. Of these, compounds 2-[(E)-(2-Benzoylhydrazinylidene)methyl]phenyl 5-(dimethylamino)naphthalene-1-sulfonate (5c, IC50 = 1.11 µM) and tert-butyl (2E)-2-[(2-{[5-(dimethylamino)naphthalene-1-sulfonyl]oxy}phenyl)methylidene]hydrazine-1-carboxylate (5b, IC50 = 11.51 µM) exhibit stronger inhibitory activity than rivastigmine, the reference compound, and exhibit high selectivity for BChE over AChE (e.g., selectivity index 57 for 5c). Interestingly, compound 5c also exhibited anti-inflammatory effects, which is important for potential therapeutic applications, especially in Alzheimer’s disease. These new compounds were designed through a structure-based approach using molecular modeling techniques (docking, molecular dynamic (MD) simulations, and QTAIM (quantum theory of atoms in molecules) calculations). The most promising compounds show no detectable toxic effects and satisfy Lipinski’s rule of five, indicating that they represent attractive starting structures for the design of new derivatives acting as specific BChE inhibitors. In addition, our results indicate that relatively simple computational techniques such as docking calculations and toxicity prediction programs can be valuable when properly used in the search of new candidates for this particular target. Docking calculations show that the more active compounds of this series reach the bottom region of the gorge interacting with residues within the active site of BChE. However, our data further suggest that the use of more precise techniques, such as MD simulations and QTAIM analysis, is necessary to obtain detailed insight into ligand–enzyme interactions. Regarding QTAIM calculations, they demonstrate that such computations are very useful to evaluate the molecular interactions of the different molecular complexes. In summary, we report a new series of sulfonate derivatives as promising starting structures for the development of new selective BChE inhibitors.

  • A predictive acetylcholinesterase inhibition model: an integrated computational approach on alkaloids and synthetic derivatives

    by Camila Adarvez-Feresin, Emilio Angelina, Oscar Parravicini, Ricardo D. Enriz, Adriana D. Garro

    Computational techniques have become powerful tools for studying biological systems, including receptor–ligand (R–L) complexes. In medicinal chemistry, these in silico approaches are widely used for modeling and predicting molecular interactions, as well as for designing new ligands with biological activity. However, obtaining a direct correlation between the structure and activity of a set of active compounds is a challenging task. This study aims to develop a computational pipeline to find a direct correlation between structure and acetylcholinesterase (AChE) inhibitory activity across a structurally diverse set of 224 Amaryllidaceae alkaloids and synthetic derivatives. Standard docking protocols failed to generate reliable correlations with experimental data, and although the inclusion of molecular dynamics (MD) simulations improved performance, the results remained insufficient for robust prediction. Incorporation of quantum theory of atoms in molecules (QTAIM) analyses on MD-refined geometries was essential to capture key R–L interactions, yielding a strong correlation with relative IC50 values (R = – 0.9131). This approach not only explained differences in activity among structurally related compounds but also distinguished active, moderately active, and inactive ligands across multiple alkaloid families. For the first time, a QTAIM analysis is reported providing detailed insights into the molecular interactions stabilizing AChE–ligand complexes, including natural alkaloids, as well as synthetic dual-site inhibitors designed to engage both the catalytic active site and the peripheral anionic site of the enzyme. These findings suggest that simple appropriately combined computational methodologies can yield predictive and explanatory models applicable to chemically diverse scaffolds, supporting the rational design of novel AChE inhibitors.

  • Open Access

    Novel Butyrylcholinesterase Inhibitor Alkaloids from Cannabis sativa Roots: Bioguided Isolation and In Silico Study

    by Javier E. Ortiz, Camila W. Adarvez-Feresin, Olimpia Llalla-Cordova, Diego Cristos, Adriana Garro, Gabriela E. Feresin

    Neurodegenerative diseases, including Alzheimer’s disease (AD), represent one of the main global health challenges. Cannabis sativa synthesizes spermidine-type alkaloids, whose potential biological activities have been little studied. This study aimed to isolate bioactive alkaloids from an alkaloid-enriched extract (AEE) of C. sativa roots throughout a bioguided approach using conventional chromatographic techniques based on AChE and BuChE inhibitory activities. A qualitative and semiquantitative analysis by UPLC-ESI-MS/MS as well as molecular modeling simulations were performed. In addition, predictive in silico analyses were conducted to assess toxicity properties. The alkaloids cannabisativine (CS) and anhydrocannabisativine (ACS) were isolated, and showed highly selective BuChE inhibitory activity. The molecular modeling study revealed a conserved interaction profile across both alkaloids, indicating the amino acids TRP82, GLU197, TYR440, and HIS438 as the major contributors involved in the complex formation. Finally, CS and ACS exhibited low in silico predictive toxicity values. In conclusion, CS and ACS alkaloids emerge as new selective BuChE inhibitors with therapeutic potential that deserves the attention from the field of pharmacology in neurodegenerative disease research. Additionally, this approach promotes innovation and environmental sustainability through the use of C. sativa roots.


  • Inhibitory effect of galantamine and donepezil combination against cholinesterase: An in silico and in vitro study

    by Camila W. Adarvez‐Feresin, Javier E. Ortiz, Mauricio D. Piñeiro, Oscar Parravicini, Ricardo D. Enriz, Adriana D. Garro, Gabriela E. Feresin

    This study aimed to evaluate the in silico and in vitro inhibitory effect of the combined use of galantamine (GAL) and donepezil (DON) against acetylcholinesterase and butyrylcholinesterase (BuChE) enzymes. In silico and in vitro cholinesterase analysis were carried out for GAL and DON alone and combined. Molecular modeling studies were carried out (docking analysis, molecular dynamics simulation, and quantum theory of atoms in molecules). Cholinesterase's inhibitory activities by modified Ellman's method and the drug combination effect using the Chou–Talalay method were assayed. GAL/DON combination showed the co‐occupancy of the ligands in both enzymes through in silico studies. Regarding in vitro BuChE inhibition analyses, three of five combinations showed an interaction between GAL and DON at the threshold of additive affect (0.9 < CI < 1.1), with a tendency toward a synergistic effect for higher concentrations. This is the first report showing the efficacy of the GAL/DON combinations inhibiting BuChE, showing the importance of analyzing the behavior of different ligands when co‐occupancy into the active site is possible. These combinations might be a possible therapy to improved efficacy, reduced doses, minor side effects, and high levels of the neurotransmitter in the synaptic space for Alzheimer's disease.